PPT-Myeloid-Specific Deletion of SIRT1 Impairs Obesity Associated Endothelial Dysfunction

Author : tatyana-admore | Published Date : 2019-12-21

MyeloidSpecific Deletion of SIRT1 Impairs Obesity Associated Endothelial Dysfunction and Atherosclerosis Ping GU MD PhD July 11 2016 Brisbane Cardiovascular diseases

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Myeloid-Specific Deletion of SIRT1 Impai..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Myeloid-Specific Deletion of SIRT1 Impairs Obesity Associated Endothelial Dysfunction: Transcript

MyeloidSpecific Deletion of SIRT1 Impairs Obesity Associated Endothelial Dysfunction and Atherosclerosis Ping GU MD PhD July 11 2016 Brisbane Cardiovascular diseases 31 Communicable maternal perinatal and nutritional conditions. PPAR . . . activation:. Endothelial function. Potential vascular benefits of PPAR activation. Cariou. B et al. . Br J Diabetes . Vasc. Dis. . 2005;5(3):126-32.. PPAR agonists.  Thrombosis.  Plaque stability. failure. First and Presenting author: Jeewan S. Titiyal. Co-authors: Tarun Arora, Manpreet Kaur, Tushar Agarwal. Affiliation: RP Centre, AIIMS, New Delhi, India. None of the authors of this poster have any financial interests. of the miR-34a-SIRT1 axis inhibits breast. cancer . stemness. Gary Xiao, Ph.D.. Professor and Director. School of Pharmaceutical Science & Technology. Dalian University of Technology. Dalian, China. PPAR . . . activation:. Endothelial function. Potential vascular benefits of PPAR activation. Cariou. B et al. . Br J Diabetes . Vasc. Dis. . 2005;5(3):126-32.. PPAR agonists.  Thrombosis.  Plaque stability. . . University of Witwatersrand. Dr Nathan October. Hina. . Naushad. , M.D., Timothy C. Greiner M.D., . Radwa. El . Behery. M.D., Greg . Bociek. M.D., . Phuong L. Nguyen . M.D. . University of Nebraska Medical Center. Mayo Clinic. History. 24-year-old . Organ-Specific, Hormonal, and . Biomechanical . Complications. Gallbladder Disease. Organ-Specific, Hormonal, and Biomechanical Complications. 3. The Paradox of Obesity and Gallbladder Disease. Effect of Obesity. barsness.gregory@mayo.edu. Gregory W. . Barsness. , MD, FACC, FAHA, FSCAI. Consultant, Internal Medicine & Cardiology and Radiology. Director, Mayo Clinic EECP Laboratory. Director, Mayo Clinic Cardiac Intensive Care Unit. Dr. . B.V.Vydehi. M.D. PROFESSOR OF PATHOLOGY. NARAYANA MEDICAL COLLEGE,NELLORE. Uncontrolled & abnormal proliferation of one of white blood cells & their precursors in the bone marrow and peripheral blood. Functional Coronary Angiography in Symptomatic Patients with No Obstructive Coronary Artery Disease . Sonali Kumar MD, Puja K. Mehta MD, Parham Eshtehardi MD, Olivia Y. Hung MD, Jin-Sin Koh MD, Arnav Kumar MD,MSCR; Ahmed Al-Badri MD, Rani Rabah, Melroy D’Souza MD, Sonu Gupta MBBS, Michael McDaniel MD, Viola Vaccarino MD PhD, John Douglas MD, Kreton Mavromatis MD, Joo Myung Lee MD MPH PhD, Arshed Quyyumi MD, Habib Samady MD. Dr Shameem . Mahmood. November 2015. 1. Division of Medicine, Royal Free Hospital Campus, National Amyloidosis Centre, University College of London Medical School, London, United Kingdom. 2. Haemophilia Department, Royal Free Hospital, . Ass.Prof.Abeer. . Anwer. Ahmed. The . leukaemias. are a group of disorders characterized by . the accumulation . of malignant white cells in the bone marrow and. blood. . These . abnormal cells cause symptoms because of: . After receiving a request from the WTC Clinical Centers of Excellence to review certain myeloid disorders in terms of their status as malignancies, 1 the WTC Health Program has determined that, 2 e g Otto Visser. June 2019. Coding issues. Introduction. For most (solid) cancers, the primary site of the most important factor for the prognosis and the choice of treatment. For other cancers, especially haematological malignancies, but also for an increasing number of solid cancers, the morphological classification is the most important factor.

Download Document

Here is the link to download the presentation.
"Myeloid-Specific Deletion of SIRT1 Impairs Obesity Associated Endothelial Dysfunction"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.